EP Wealth Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$262K	Buy	12,063 +28	+0.2%	+$608	﹤0.01%	1100
2025 Q1	$292K	Buy	12,035 +1,504	+14%	+$36.5K	﹤0.01%	921
2024 Q4	$220K	Buy	+10,531	New	+$220K	﹤0.01%	1026